Open AccessNew prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis
Author(s) -
Theodora Oikonomou,
Αfroditi Orfanidou,
Ioannis Goulis,
Fani Ntogramatzi,
Zoi Athanasiadou,
George Papatheodoridis,
Εvangelos Cholongitas
Publication year - 2021
Publication title -
annals of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 33
eISSN - 1792-7463
pISSN - 1108-7471
DOI - 10.20524/aog.2021.0633
Subject(s) - medicine , interquartile range , confidence interval , gastroenterology , renal function , hazard ratio , cirrhosis , receiver operating characteristic , area under the curve , model for end stage liver disease , liver disease , liver transplantation , transplantation
Galectin-3 (gal-3) has been proposed as a marker of established renal impairment, with predictive value in stable decompensated cirrhosis.